At Kingston University, I’m researching ways to optimize dry powder inhaler formulations for asthma and COPD. I blend formulations, assess their properties and aerodynamic performance, and validate CFD-DEM models against experimental data.
My PhD work examines ternary agents including MgSt, glycine, leucine, and Pluronic F-127. I use Quality by Design and Taguchi Design of Experiments to support formulation optimization.
At Newcastle University, I developed and optimized protein inhibitors targeting Complement Component C5, using bioassays, pre-formulation studies, and compound characterization techniques. My earlier research at the University of Crete focused on synthesizing and characterizing novel organic compounds for pharmaceutical applications.

